Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
CLERX AdvisorOne CLS Growth and Income Fund Class N
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
CNBS Amplify Seymour Cannabis ETF
RBCAA Republic Bancorp Inc
IMTE Integrated Media Technology Ltd
GECC Great Elm Capital Corp
SCX L S Starrett Co
VFIAX Vanguard 500 Index Fund Admiral Shares
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$76.42
Day's Change
-0.34 (-0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
76.96
Day's Low
76.31
Volume
(Light)
Volume:
5,055,744

10-day average volume:
7,818,121
5,055,744
  • Prev Close
    76.76
  • Today's Open
    76.49
  • Day's Range
    76.31-76.96
  • Avg Vol (10-day)
    7.8M
  • Last (time)
    4:00p ET 07/07/20
  • Last (size)
    2
  • 52-Wk Range
    60.89 - 85.97
    LowHigh
  • (10/03/19 - 03/19/20)
    11.11%
  • 37.2%
  • Market Cap
    95.9B
  • Shares Outstanding
    1.3B
  • 3.89
  • 19.73x
  • $2.72/3.54%
  • Ex-dividend Date
    06/11/20
  • Dividend Pay Date
    06/29/20
  • 0.7
  • 79.91
  • (% of float 06/15/20)
    2.02

Latest News

July 07, 2020
4:45 pm ET
Zacks
July 04, 2020
12:22 pm ET
MarketWatch
3:01 am ET
BusinessWire
3:01 am ET
BusinessWire
July 03, 2020
9:45 am ET
MarketWatch
7:56 am ET
BusinessWire
July 01, 2020
9:50 am ET
MarketWatch
8:30 am ET
BusinessWire
June 30, 2020
6:11 am ET
MarketWatch
June 29, 2020
3:55 pm ET
BusinessWire
10:47 am ET
MarketWatch
10:30 am ET
PR Newswire
9:12 am ET
MarketWatch
7:07 am ET
MarketWatch
7:06 am ET
MarketWatch
7:05 am ET
MarketWatch
7:04 am ET
MarketWatch
7:00 am ET
BusinessWire
June 24, 2020
5:34 am ET
BusinessWire
June 23, 2020
8:30 am ET
BusinessWire
7:00 am ET
BusinessWire
3:00 am ET
PR Newswire
June 22, 2020
9:34 am ET
MarketWatch
6:00 am ET
PR Newswire
June 20, 2020
12:11 pm ET
MarketWatch
June 19, 2020
4:32 pm ET
MarketWatch
June 18, 2020
3:37 pm ET
PR Newswire
June 17, 2020
4:33 pm ET
MarketWatch
June 16, 2020
4:05 pm ET
BusinessWire
9:19 am ET
MarketWatch
June 15, 2020
6:19 pm ET
MarketWatch
7:37 am ET
MarketWatch
June 12, 2020
8:00 am ET
BusinessWire
6:24 am ET
Globe Newswire
June 08, 2020
10:50 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.